Dalmia Group Launches

dalmia-group-launches

New Delhi, 13 March, 2020: Dalmia Group is launching Herbal Composition "dhl Coronavirus Preventive Capsule" for prevention against COVID-19. The medicine will be launched on 16th March 2020 in New Delhi, to be available for purchase across all pharmacies in Delhi NCR. It will also be available all over India through the online retail platform, Dalmia Best Price (dalmiabestprice.in). The medicine is priced at Rs. 480 for 60 capsules


Mr. Sanjay Dalmia, Chairman, Dalmia Group of companies, said, "dhl Coronovirus Preventive capsule, a polyherbal combination can be effectively used for the prevention against Coronavirus as it will work mainly on the immune system to further boost it and acts as a bronchodilator, decongestant, anti-inflammatory and lung detoxifier. It helps in eliminating the infection and regulating the allergic reactions. This has specific action on the mucosa of the respiratory tract and the muscular walls off the lungs that act as the airways. It has anti-inflammatory effect which reduces inflammation and congestion inside the lungs. Its continuous usage reduces the damage on lungs and the muscular walls and bring out significant reversal in their dysfunction." 


Dalmia Centre for Research and Development (DCRD), after many years of extensive research developed a polyherbal combination of 15 herbs called Astha -15 and we have derived dhl Coronavirus preventive capsule from the same composition and all the important herbs mentioned in the Indian System of Medicine. dhl Coronavirus preventive capsule originally as Astha-15 has undergone a randomized double blind, placebo-controlled study on patients Speciality Govt. Hospital for Thoracic medicine, Chennai, India under the watchful eyes of internationally recognized respiratory physicians who followed a peer reviewed ethically approved clinical protocol to assess the efficacy of dhl Coronavirus in comparison to the modern medicines.  

 

The unique blend of 15 herbs involved in dhl Coronavirus provide immunity to the person. It also acts as a bronchodilator, decongestant, anti-inflammatory and lung detoxifier. According to the double-blind study using DCBT4567 – dhl Coronavirus, it was found that the patients tested had significant reduction (95% significance) in dyspnoea, wheezing cough, expectoration, disability and sleep disturbances. dhl Coronavirus which was originally taken from the brand Astha-15 did not exhibit any of the side-effects normally observed with allopathic drugs.  

 

COVID-19 also known as Coronavirus has affected more than 87,000 people across the world. It has flu like symptoms which includes running nose, cough, fever, body pain and breathlessness. Lungs are exposed to approximately 7000 litres of air every day. The viruses being air-borne are inhaled through the nose and reaches the lungs where it attacks the cell machinery and starts the replication thus lowering the immunity of the host and causing flu-like symptoms in the body. The breathlessness caused by the virus is also due to the loss of the lining of the alveolar cells.

 

Herbs and plants naturally contain many active chemicals and thus drugs derived from such sources can have multiple health benefits when administered to patients. Due to the presence of multiple active compounds in phytomedicines, they are an ideal candidate for treating conditions with a variety of symptoms such as inflammatory diseases which affect multiple systems.

 

Herbal medicine-derived natural products can be considered as an alternative therapeutic potential for respiratory diseases since several compounds showed anti-inflammatory effects inhibition different inflammatory mediators involved in respiratory diseases.

 

It is believed that the natural products derived from plants inhibit the pulmonary inflammation by the inhibition of the transcription of NF-κB to the nucleus, thus preventing the development of all the inflammatory processes triggered by allergen, cigarette smoke, virus, or bacteria. Therefore, herbal supplements can reduce the inflammatory cytokines release and oxidative stress. These effects together culminate with the improvement of lung function and with the reduction of pulmonary inflammation.

 

Most of the studies are pointing out the effects of natural products on the inhibition of NF-κB and MAPK pathways, besides the antioxidant effects associated with these products.